US Director, Genitourinary Payor & Access Strategy Lead, Medical Affairs, Health Systems Oncology

Job Description

Role Summary

• The US Director, Payor & Access Strategy Lead, Medical Affairs (PASL) is responsible for US Field Medical (FM) strategy, training, and prioritization of the Value & Implementation (V&I) plan for USMA Health Systems Oncology (HSO). The PASL for health systems oncology is an impactful member of US Medical Affairs (USMA) cross-functional teams, US Medical Affairs Teams (USMAT), and Value Teams (VT).

• The therapeutic area responsibilities of the US PASL are based on priorities and are subject to change as organizational and US HSO needs evolve. For this role, the US PASL will manage therapeutic areas including genitourinary cancers (urothelial, renal, prostate) and selected oncology asset(s).

• The US PASL drives US HSO strategic excellence and optimizes HSO and USMA readiness in support of payor access, pharmacoeconomic and scientific exchange aligned to Global V&I plan priorities. This is a regionally based position (US) in our company’s Research and Development (R&D) division.

Responsibilities and Primary Activities

• Responsible for the direction, coordination, implementation, control, and execution of USMA and HSO payor and access strategy for defined cancers and assets while remaining aligned to global medical and commercial strategy, commitments, and goals. Leads the US HSO integrated Field Medical (FM) plan process in collaboration with US HSO Executive Director (US HSO ED), US HSO Sr. Director PASL, US HSO Team Leads, and other members of the global and regional cross-functional teams.

• Develop and direct payor and access strategy in alignment with organizational priorities and unmet needs

• Collects, analyzes, and communicates scientific insights from US HSO Medical Affairs Director (MAD) field engagements to inform company strategies across our Research and Development Division/V&I, which includes Global Medical and Scientific Affairs (GMSA) and Outcomes Research (OR), and Commercial.

• Leads US Payor Access Team (US PAT) to support prioritizing US gaps/needs assessment, value evidence strategy and tactical plan for global V&I annual planning input (e.g., one-pager, V&I and CMAP plans).

• Serves as US Health Systems Oncology interface between GMSA, Commercial, and other relevant headquarters (HQ) functions and the US HSO Team

• Identifies and prioritizes US HSO field resources, training needs, and activities across the oncology portfolio to optimize HSO MAD Field Team readiness

• Collaborates with key stakeholders to define/implement strategic congress priorities for USHSO and coordinates planning of HSO MAD activities at key scientific congresses

• Continuously scans the healthcare environment and quality landscape to analyze emerging trends in the oncology therapeutic and competitive landscape, in addition to market access to optimize US Field HSO Team capabilities

• Represents USMA HSO, in partnership with GMSA, in Expert Input Forums or Advisory Boards, as needed

Required Qualifications, Skills, & Experience

Minimum

• Advanced healthcare/science degree (MD, PhD, or PharmD)

• 5+ years of prior pharmaceutical industry experience, (preferably Field Medical experience or equivalent biotech/pharmaceutical/Medical Affairs strategy experience), within oncology

  • OR 5+ years of experience working in quality/managed care/cancer center settings, with demonstrated oncology scientific acumen

  • OR Board Certified Oncology Pharmacist (BCOP)/Board Certified Pharmacotherapy Specialist (BCPS) with 5+ years of clinical experience working within a cancer center

  • OR equivalent

• Demonstrated ability to create and implement a strategic plan

• Excellent interpersonal, communication, networking, and results-oriented project management skills

• Thorough knowledge of clinical medicine, US healthcare delivery system structure and function, pharmacoeconomics, population health management, quality management, value-based payment, and healthcare delivery policy and trends

• Demonstrated ability to effectively work in a complex, matrixed environment (promoting inclusion, maintaining trust, and respecting others)

• Ability to network and partner with important internal and external stakeholders, including cross functional teams, scientific leaders, and key decision makers

• Knowledge of national and society treatment guidelines, clinical research processes, FDA regulations, and Office of the Inspector General (OIG), Health Insurance Portability and Accountability Act (HIPAA), and other ethical guidelines, laws, and